EuropaBio is pleased to announce that this year's edition of EFIB, Europe’s Leading Event on Industrial Biotechnology and the Bioeconomy under the title 'Industrial biotechnology for a sustainable and resilient global […]
The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.
This panel will discuss what the legislation brings, its potential impact on businesses and what needs to be done to change the legislation in its journey to a final version, that it works for both, the biotech ecosystem, maintaining innovation pipelines, and patients.
Hybrid Event | Invitation Only EuropaBio’s Patient BioForum meets annually to facilitate the exchange of views and expertise on scientific, regulatory, and policy issues between patient […]
Industrial biotechnology for a sustainable and resilient global Europe As the EU looks ahead to the European elections in 2024, with a new EU Commission mandate […]
The IHI Call Days are your one-stop-shop to get detailed information on our calls for proposals and network with potential partners for your consortium.
Event agenda 12:00: Registration opens 12:30: Panel starts 13:45: Panel close and networking lunch 15:00: Close Confirmed Speakers Tomislav Sokol MEPMember SANT Committee, European Parliament Hilde […]
Join our very own Healthcare Policy Senior Manager, Adrien Samson in Madrid where he will be speaking in the panel "Innovation, Funding and Access to Orphan Drugs: Challenges and Opportunities" between 12:15 and 13:00.
Whether it’s microorganisms revolutionising manufacturing or advanced therapies for rare disease patients, biotechnology is leading the way, and Belgium is on it. If you are a […]
Join us on 7 March to discuss the impact of revision of the EU’s General Pharmaceutical Legislation (GPL) on Europe’s innovation ecosystem and biotechnology companies.
Join us on 7 March to discuss the impact of revision of the EU’s General Pharmaceutical Legislation (GPL) on Europe’s innovation ecosystem and biotechnology companies.
The Biomanufacturing Policy Summit will host its 2nd edition in March 2024. The invite-only half-day summit hosted by EuropaBio brings together stakeholders including industry representatives and […]
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
